Oleclumab (MEDI9447)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Oleclumab (MEDI9447), covering 2022-07-26 to 2025-06-19. Get the full timeline:
Most recent: Clinical Trial Update: Testing the Safety of Adding Either Monalizumab (IPH2201) or Oleclumab (MEDI9447) to Durvalumab (MEDI4736) Plus Standard Radiation Therapy for Locally Advanced Non-small Cell Lung Cancer (NSCLC), ARCHON-1 Trial [Phase 1]